BioCentury
ARTICLE | Clinical News

Dalbavancin: Additional Phase III data

January 21, 2013 8:00 AM UTC

In a subgroup of patients with methicillin-resistant Staphylococcus aureus (MRSA), dalbavancin led to an early response defined as cessation of spread of the erythema of the lesion and resolution of f...